Skip to main content
. 2023 Jul 2;3(4):20210058. doi: 10.1002/EXP.20210058

FIGURE 2.

FIGURE 2

Diverse ACT platforms. ACTs mainly include Tumor‐infiltrating lymphocyte (TIL) therapy, T‐cell receptor (TCR) therapy, Chimeric antigen receptor (CAR) T cell/NK cell/macrophage therapy, and Dendritic cell (DC) therapy. Figure created using Biorender.com.